Aarti Pharma

31
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
721.55
-1.9 (-0.26%)
BSENSE

Dec 05

BSE+NSE Vol: 1.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Operating Income
2,115.00
1,852.00
1,945.00
1,199.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
2,115.00
1,852.00
1,945.00
1,199.00
Expenditure (Ex Depriciation)
Stock Adjustments
64.00
-19.00
-125.00
-49.00
Raw Materials Consumed
1,063.00
1,040.00
1,295.00
745.00
Power & Fuel Cost
81.00
84.00
75.00
44.00
Employee Cost
161.00
138.00
129.00
85.00
Operating Expenses
128.00
116.00
93.00
132.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
60.00
49.00
55.00
25.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
33.00
29.00
33.00
7.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
1,650.00
1,466.00
1,603.00
992.00
Operating Profit (PBDIT) excl Other Income
464.00
386.00
342.00
206.00
Other Income
10.00
4.00
2.00
2.00
Operating Profit (PBDIT)
474.00
390.00
344.00
209.00
Interest
26.00
17.00
21.00
11.00
Profit before Depriciation and Tax
447.00
373.00
323.00
197.00
Depreciation
86.00
73.00
62.00
42.00
Profit Before Taxation & Exceptional Items
360.00
300.00
260.00
155.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
360.00
300.00
260.00
155.00
Provision for Tax
88.00
83.00
67.00
33.00
Profit After Tax
272.00
216.00
193.00
122.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
1,085.00
889.00
717.00
0.00
Profit Available for appropriations
1,358.00
1,106.00
910.00
122.00
Appropriations
1,358.00
1,106.00
910.00
122.00
Equity Dividend (%)
100.00%
60.00%
40.00%
0.00%
Earnings Per Share
30.06
23.93
21.35
13.49
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.17% vs -4.76% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 20.29% vs 12.86% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 56.24% vs -18.23% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 25.59% vs 12.10% in Mar 2024

Compare Profit and Loss Results of Aarti Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,115.00
1,151.00
964.00
83.75%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,115.00
1,151.00
964.00
83.75%
Expenditure (Ex Depriciation)
Stock Adjustments
64.00
-34.00
98.00
288.24%
Raw Materials Consumed
1,063.00
442.00
621.00
140.50%
Power & Fuel Cost
81.00
52.00
29.00
55.77%
Employee Cost
161.00
281.00
-120.00
-42.70%
Operating Expenses
128.00
49.00
79.00
161.22%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
60.00
15.00
45.00
300.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
33.00
18.00
15.00
83.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,650.00
907.00
743.00
81.92%
Operating Profit (PBDIT) excl Other Income
464.00
244.00
220.00
90.16%
Other Income
10.00
8.00
2.00
25.00%
Operating Profit (PBDIT)
474.00
252.00
222.00
88.10%
Interest
26.00
91.00
-65.00
-71.43%
Profit before Depriciation and Tax
447.00
160.00
287.00
179.38%
Depreciation
86.00
107.00
-21.00
-19.63%
Profit Before Taxation & Exceptional Items
360.00
52.00
308.00
592.31%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
360.00
54.00
306.00
566.67%
Provision for Tax
88.00
22.00
66.00
300.00%
Profit After Tax
272.00
36.00
236.00
655.56%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,085.00
1,001.00
84.00
8.39%
Profit Available for appropriations
1,358.00
1,033.00
325.00
31.46%
Appropriations
1,358.00
1,033.00
325.00
31.46%
Equity Dividend (%)
100%
0%
100.00
Earnings Per Share
30.06
3.67
26.39
719.07%
Profit And Loss - Net Sales
Net Sales 2,115.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.17% vs -4.76% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 464.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.29% vs 12.86% in Mar 2024

Profit And Loss - Interest
Interest 26.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 56.24% vs -18.23% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 272.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.59% vs 12.10% in Mar 2024